Chylomicron: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
(6 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Chylomicron}} | ||
{{CMG}}; {{AE}} {{AN}}; {{RT}} | {{CMG}}; {{AE}} {{AN}}; {{RT}} | ||
== [Chylomicron overview|Overview]] == | == [[Chylomicron overview|Overview]] == | ||
== [Chylomicron historical perspective|Historical Perspective]] == | == [[Chylomicron historical perspective|Historical Perspective]] == | ||
== [Chylomicron classification|Classification]] == | == [[Chylomicron classification|Classification]] == | ||
== [Chylomicron biochemistry|Biochemistry]] == | == [[Chylomicron biochemistry|Biochemistry]] == | ||
== [Chylomicron physiology|Physiology]] == | == [[Chylomicron physiology|Physiology]] == | ||
== Clinical Correlation== | == Clinical Correlation== | ||
===[[High | ===[[High chylomicron]]=== | ||
[[High | [[High chylomicron definition|Definition]] | [[High chylomicron epidemiology and demographics|Epidemiology and Demographics]] | [[High chylomicron pathophysiology|Pathophysiology]] | [[High chylomicron causes|Causes]] | [[High chylomicron prognosis and complications|Prognosis and Complications]] | ||
===[[Low | ===[[Low chylomicron]]=== | ||
[[Low | [[Low chylomicron definition|Definition]] | [[Low chylomicron epidemiology and demographics|Epidemiology and Demographics]] | [[Low chylomicron epidemiology and demographics|Epidemiology and Demographics]] | [[Low chylomicron pathophysiology|Pathophysiology]] | [[Low chylomicron causes|Causes]] | [[Low chylomicron prognosis and complications|Prognosis and Complications]] | ||
== Treatment == | == Treatment == | ||
[Chylomicron medical therapy|Medical Therapy]] | [Chylomicron primary prevention|Primary Prevention]] | [Chylomicron secondary prevention|Secondary Prevention]] | [Chylomicron landmark trials|Landmark Trials]] | [Chylomicron future or investigational therapies|Future or Investigational Therapies]] | [[Chylomicron medical therapy|Medical Therapy]] | [[Chylomicron primary prevention|Primary Prevention]] | [[Chylomicron secondary prevention|Secondary Prevention]] | [[Chylomicron landmark trials|Landmark Trials]] | [[Chylomicron future or investigational therapies|Future or Investigational Therapies]] | ||
{{Lipoproteins}} | {{Lipoproteins}} | ||
Line 28: | Line 28: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Lipoproteins]] | [[Category:Lipoproteins]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Latest revision as of 22:18, 16 September 2013
Chylomicron Microchapters |
Clinical Correlation |
---|
Treatment |
Case Studies |
Chylomicron On the Web |
American Roentgen Ray Society Images of Chylomicron |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]
Overview
Historical Perspective
Classification
Biochemistry
Physiology
Clinical Correlation
High chylomicron
Definition | Epidemiology and Demographics | Pathophysiology | Causes | Prognosis and Complications
Low chylomicron
Definition | Epidemiology and Demographics | Epidemiology and Demographics | Pathophysiology | Causes | Prognosis and Complications
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Landmark Trials | Future or Investigational Therapies